Verastem reported $77.74M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alaunos Therapeutics USD 2.38M 172K Mar/2026
AstraZeneca USD 1.55B 73K Mar/2026
Curis USD 12.93M 12.87M Dec/2025
Cytokinetics USD 124.43M 2.17M Mar/2026
Gilead Sciences USD 1.24B 1000K Mar/2026
Incyte USD 199.95M 1.49M Mar/2026
Laboratory Of America USD 82.3M 100K Mar/2026
Novartis USD 1.91B 60K Mar/2026
Pfizer USD 5.7B 13M Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
TG Therapeutics USD 155.31M 95K Dec/2025
Verastem USD 77.74M 77.74M Dec/2025